Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors

被引:37
|
作者
Zettl, Heiko [1 ]
Schubert-Zsilavecz, Manfred [1 ]
Steinhilber, Dieter [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany
关键词
DPP-4; inhibitors; drug discovery; incretin mimetics; medicinal chemistry; DIPEPTIDYL-PEPTIDASE-IV; GLUCAGON-LIKE PEPTIDE-1; TYPE-2; DIABETES-MELLITUS; ANTIHYPERGLYCEMIC PROPERTIES; HEALTHY-VOLUNTEERS; RECEPTOR AGONISTS; CRYSTAL-STRUCTURE; POTENT; PHARMACOKINETICS; PHARMACODYNAMICS;
D O I
10.1002/cmdc.200900448
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:179 / 185
页数:7
相关论文
共 50 条
  • [21] Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)
    Thornberry, Nancy A.
    Gallwitz, Baptist
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 479 - 486
  • [22] Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
    Farngren, Johan
    Ahren, Bo
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 99 : 25 - 31
  • [23] DPP-4 inhibitors: a patent review (2012-2014)
    Costante, Roberto
    Stefanucci, Azzurra
    Carradori, Simone
    Novellino, Ettore
    Mollica, Adriano
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (02) : 209 - 236
  • [24] A comprehensive review on potential drug-drug interactions of proton pump inhibitors with antidiabetic drugs metformin and DPP-4 inhibitors
    Tasnim, Jarin
    Hashim, Najihah Mohd
    Han, Heh Choon
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (02)
  • [25] DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics
    Krittanawong, Chayakrit
    Xanthopoulos, Andrew
    Kitai, Takeshi
    Branis, Natalia
    Zhang, HongJu
    Kukin, Marrick
    HEART FAILURE REVIEWS, 2018, 23 (03) : 355 - 361
  • [26] Cardiovascular outcome studies with incretin-based therapies: Comparison between DPP-4 inhibitors and GLP-1 receptor agonists
    Scheen, Andre J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 127 : 224 - 237
  • [27] Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A New Oral Alternative
    Kintscher, U.
    DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (03): : 169 - 175
  • [28] Evaluation of drug efficacy of DPP-4 inhibitors based on theoretical analysis with pharmacokinetics and pharmacodynamics
    Takayanagi, Risa
    Uchida, Takumi
    Kimura, Koji
    Yamada, Yasuhiko
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (04) : 273 - 279
  • [29] Pharmacoeconomic analysis of DPP-4 inhibitors
    Teramachi, H.
    Ohta, H.
    Tachi, T.
    Toyoshima, M.
    Mizui, T.
    Goto, C.
    Tsuchiya, T.
    PHARMAZIE, 2013, 68 (11): : 909 - 915
  • [30] DPP-4 Inhibitors in Clinical Practice
    Palalau, Anna I.
    Tahrani, Abd A.
    Piya, Milan K.
    Barnett, Anthony H.
    POSTGRADUATE MEDICINE, 2009, 121 (06) : 70 - 100